Cardiomyocytic cGAS is critical for the induction of experimental cardiac graft rejection

Zelai Wu,Xiaolong Miao,Yuancong Jiang,Deqiang Kong,Han Liu,Weixun Xie,Bingfeng Shi,Weihua Gong
DOI: https://doi.org/10.1016/j.jtcvs.2023.03.005
IF: 6.439
2023-03-13
Journal of Thoracic and Cardiovascular Surgery
Abstract:Objective During cardiac transplantation, cellular injury and DNA damage can result in the accumulation of cytosolic double strains DNA (dsDNA), which can activate the cyclic GMP-AMP synthase (cGAS)/stimulator of interferon gene (STING) signaling pathway and thus induce multiple proinflammatory responses. However, the role of the cGAS-STING pathway in cardiac transplantation remains unclear. This study explored the role of cardiomyocytic cGAS in mouse heart transplantation during the ischemia/reperfusion and rejection processes. Methods and Results Cytosolic dsDNA accumulation and cGAS-STING signaling pathway component upregulation were observed in the grafts post transplantation. The use of cGAS-deficient donor tissues led to significantly prolonged graft survival. The underlying mechanisms involved decreased expression and phosphorylation of downstream proteins, including TBK1 and NF-κB. In parallel, notably diminished expression levels of various proinflammatory cytokines were observed. Accordingly, substantially decreased proportions of macrophages (CD11b + F4/80 + ) and CD8 + T cells were observed in the spleen. The activation of CD8 + T cells (CD8 + CD69 + ) within the graft and the proportion of effector memory (CD44 high CD62L low ) lymphocytes in the spleen were notably decreased. Treatment with the cGAS inhibitor Ru.521 led to significantly prolonged graft survival. Conclusions In conclusion, cardiomyocytic cGAS plays a critical role by sensing cytosolic dsDNA during cardiac transplantation and could serve as a potential therapeutic target to prevent graft rejection.
surgery,cardiac & cardiovascular systems,respiratory system
What problem does this paper attempt to address?